VF
PETX

Virtu Financial’s Aratana Therapeutics, Inc. PETX Stock Holding History

Virtu Financial’s Portfolio PETX Stock Details PETX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-15,314
Closed -$68K – 2752
2018
Q1 		$68K Buy
15,314
+2,296
+18% +$10.2K ﹤0.01% 1652
2017
Q4 		$68K Buy
+13,018
New +$79.6K ﹤0.01% 2010

Other funds holding PETX

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GAI
General American Investors New York $1.52B AUM 37.94% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
GPGA
Grandeur Peak Global Advisors Salt Lake City, Utah $427M AUM 39.14% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Virtu Financial's PETX Position: Q2 2018 in Review

Virtu Financial sold out of Aratana Therapeutics, Inc. (PETX) in Q2 2018, closing a stake of 15,314 shares — an estimated $68K sold.

Virtu Financial first reported a position in PETX in Q4 2017 and held it in 2 quarters. The position peaked at $68K in Q1 2018. 105 funds tracked by Wall St. Rank hold PETX as of Q2 2018.

  • Virtu Financial reported no remaining Aratana Therapeutics, Inc. position as of Q2 2018 after selling out during the quarter.
  • Virtu Financial sold 15,314 Aratana Therapeutics, Inc. shares in Q2 2018, an estimated $68K.
  • Virtu Financial first reported a position in Aratana Therapeutics, Inc. in Q4 2017 and held it in 2 quarters.
  • Virtu Financial's Aratana Therapeutics, Inc. position peaked at $68K in Q1 2018.
  • 105 funds tracked by Wall St. Rank held Aratana Therapeutics, Inc. as of Q2 2018.

Based on Virtu Financial's 13F filing for Q2 2018, filed 30 Jul 2018.